Perthera for Patients

Perthera’s Precision Oncology Platform to advance your care.

How Do I Get Started?

Advance your care at no cost to you!

Click here to contact a member of Perthera’s Clinical team. We will answer any questions you may have and review the next steps to get you started with Perthera Analytics.

If you have any additional questions, email Perthera at: hope@perthera.com or call us (571) 252-8343 to speak directly to one of our dedicated Clinical Coordinators.
What Is Perthera?

A Precision Oncology company utilizing Artificial Intelligence (AI) to generate ranked treatment recommendations personalized for your specific cancer.

Recommendations are clinically proven to extend patient lives and outcomes and Used by over 250 Cancer Treatment Centers and 10% of oncologists across all 50 states.

What Will Perthera Do for Me?

Proven in numerous clinical studies to advance patients’ overall & progression-free survival

  • Treatment options are precisely matched to you, your molecular profile, and treatment history
  • Ranked therapy options provided at no cost
  • Simple & concise Report delivered to help guide your medical decision making

  • Sign the consent, and Perthera does the rest!
  • We coordinate the entire process once the simple, one-page consent is completed
  • Lab testing is seamlessly coordinated, and our Report delivered within 2 days of the results

  • Clinical trials have been proven to dramatically extend patient survival rates
  • Perthera’s Report precisely matches patients to treatments and clinical trials to support your doctor’s medical decision making and your care pathway
  • Recommendations are personalized for your location and tumor profile for precise matching to the best treatments and trials for you

  • Perthera tracks and captures your improved outcomes to advance cancer care for all patients across the country through research and publications
Perthera makes precision oncology possible. Through Perthera’s robust multiomic and computational approaches, clinicians are now able to match the precise therapies that best target a specific tumor for each individual patient. Perthera’s approach sets a new standard for cancer care.
Geoffrey W. KrampitzMD, PhD
The analysis are awesome and the support and updates from the staff also
Dr. Jose AcostamadiedoMD
Hi, my name is Maria Heliana Vivas Morales, I am Venezuelan, and I currently live in Colombia. Seven years ago I was diagnosed with breast cancer, a malignant tumor from the upper outer quadrant of the breast, it was a bilateral tumor, Stage III. I received treatment with chemotherapy followed by surgery continued with chemotherapy again and radiation therapy. I was placed on hormonal therapy for 5 years having a recurrence in 2020. The recurrence was in lung and liver; this was followed by another surgery where biopsies were taken, and molecular studies were done that were sent to Perthera, who did the analysis and suggested several treatment options. I was started on one of the options, and I have had a stupendous recovery with disappearance of the lung lesions and liver lesions with No Evidence of Disease
Maria Heliana Vivas MoralesPerthera Patient
Previous
Next
Perthera makes precision oncology possible. Through Perthera’s robust multiomic and computational approaches, clinicians are now able to match the precise therapies that best target a specific tumor for each individual patient. Perthera’s approach sets a new standard for cancer care.
Geoffrey W. KrampitzMD, PhD